President Donald Trump has announced a new tariff on imported generic pharmaceutical drugs, aiming to encourage domestic manufacturing. The 100% tariff will take effect in August 2028, with a phased schedule intended to give drugmakers time to move production to the United States. The policy is designed to reduce reliance on foreign suppliers and strengthen the American pharmaceutical industry. The move targets generic drugs, which are often produced overseas at lower cost. The administration expects the tariff to push companies to invest in U.S.-based facilities. The announcement was made on Tuesday, and the tariff is set to be implemented over several years to allow for a gradual transition. Critics argue the tariff may increase drug prices in the short term, but supporters say it will create jobs and secure supply chains. The plan is part of broader efforts to boost domestic production of essential medicines. The White House stated that the tariff will help ensure a stable supply of affordable generic drugs for Americans in the long run.